Bicalutamide Tablets IP 50mg
Bicalutamide Tablets IP 50mg is an oral antiandrogen medication that helps manage prostate cancer by reducing the effect of male hormones on cancer cells. It contains bicalutamide as its active ingredient, which works by blocking androgen receptors and supporting hormone-based cancer treatment approaches. This medicine is commonly used as part of a comprehensive treatment plan recommended by healthcare professionals. It offers convenient tablet-based administration and supports targeted hormonal therapy for eligible patients. Always use this medicine under medical supervision to ensure safe and effective treatment outcomes.
Description
Bicalutamide Tablets IP 50mg – Product Description
Bicalutamide Tablets IP 50mg is an advanced hormonal therapy medicine that healthcare professionals use to support the treatment of prostate cancer. This medicine contains bicalutamide as its active ingredient, which belongs to the class of non-steroidal antiandrogens. It works by blocking androgen receptors and reducing the action of male hormones that can influence the growth of prostate cancer cells.
Bicalutamide Tablets IP 50mg supports androgen deprivation therapy by controlling hormone activity in the body. Doctors may prescribe this medicine along with other treatments to improve therapeutic outcomes for suitable patients. The tablet form provides convenient oral administration and helps patients follow their prescribed treatment schedules effectively.
This medication plays an important role in prostate cancer management because it targets hormone-related pathways involved in cancer progression. By limiting androgen stimulation, the medicine helps healthcare providers manage hormone-sensitive prostate cancer as part of a complete treatment plan. Patients should take this medicine only according to their doctor’s instructions to achieve safe and effective results.
Bicalutamide Tablets IP 50mg offers consistent dosage delivery and supports long-term hormonal therapy when recommended by a healthcare professional. Doctors evaluate each patient’s condition, medical history, and treatment requirements before prescribing this medicine. Regular medical monitoring helps healthcare providers assess treatment response and manage possible side effects.
This medicine requires proper storage and careful handling to maintain its quality and effectiveness. Patients should store the tablets in a cool, dry place and protect them from moisture and direct sunlight.
It provides a targeted approach for managing prostate cancer through hormone regulation. Its antiandrogen properties make it a valuable option in oncology care when doctors include it in an appropriate treatment strategy. Always consult a qualified healthcare professional before starting, changing, or stopping this medication.
- Product Name: Bicalutamide Tablets IP 50mg
- Active Ingredient: Bicalutamide 50mg
- Therapeutic Category: Antiandrogen / Hormonal Cancer Therapy
- Drug Class: Non-steroidal Antiandrogen
- Dosage Form: Oral Tablets
- Strength: 50mg
- Primary Use: Supportive hormonal treatment for prostate cancer
- Mechanism: Blocks androgen receptors to reduce hormone stimulation of cancer cells
- Administration: Taken orally as directed by a healthcare professional
- Storage: Store in a cool, dry place away from direct sunlight
- Prescription Status: Prescription medicine
